Thomas H. Lee

Thomas H. Lee

Chief Tech/Sci/R&D Officer at PRESS GANEY HOLDINGS INC

70 year
Consumer Services
Health Services
Technology Services

Profile

Thomas H.
Lee
is currently the Director at Geisinger Clinic and a Director at Health Leads, Inc. He is also a Member-Overseers Board at Weill Cornell Medical College, a Professor at Harvard T.H.
Chan School of Public Health, a Member-Editorial Board at New England Journal of Medicine, and the Chief Medical Officer at Press Ganey Associates LLC.
Previously, he was the Chief Executive Officer at Mass General Brigham Community Physicians, Inc. and the Network President at Mass General Brigham, Inc. He holds a doctorate degree from Weill Cornell Medical College, a graduate degree from Harvard T.H.
Chan School of Public Health, and an undergraduate degree from Harvard College.

Thomas H. Lee active positions

CompaniesPositionStart
PRESS GANEY HOLDINGS INC Chief Tech/Sci/R&D Officer 2012-12-31
Director/Board Member 2005-11-30
Corporate Officer/Principal -
Harvard T.H. Chan School of Public Health Corporate Officer/Principal -
Director/Board Member -
Weill Cornell Medical College Corporate Officer/Principal -
All active positions of Thomas H. Lee

Former positions of Thomas H. Lee

CompaniesPositionEnd
Chief Executive Officer -
Corporate Officer/Principal -
See the detail of Thomas H. Lee's experience

Training of Thomas H. Lee

Weill Cornell Medical College Doctorate Degree
Harvard T.H. Chan School of Public Health Graduate Degree
Harvard College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas H. Lee's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies6

Commercial Services

Health Services

Health Services

Technology Services

Technology Services

Health Services

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW